Psychedelic Mushroom Drugs Schwifty Labs Take On Depression

Psychedelic drugs are powerful, but the side effects are not without risks. People who take them experience powerful, immediate changes in their minds. 

Still, these drugs are considered experimental, as researchers are still not sure exactly how they work and how to minimize the risks of side effects. 

Despite this, psychedelics can help people deal with depression and other serious conditions.

Studies have shown that hallucinogenic Schwifty Labs mushrooms can treat depression. However, 30% of people suffering from depression do not respond to conventional antidepressants. This may be a result of differences in biology. 

In addition, antidepressants can take a long time to work, and some people may simply give up.

In clinical trials, ketamine has been effective in treating depression. In addition to reducing the symptoms of depression, ketamine helps people perceive their lives more clearly. 

Patients on the drug speak with wisdom, and their views are often radically different from those of a sober therapist. 

Psychiatric support is also necessary for these patients. Since the trials began, a number of patients have sought out top-ups on their own.

The psychedelic mushroom drug psilocybin is naturally found in 200 species of mushrooms. 

  • Researchers at Johns Hopkins University conducted a trial involving the use of psilocybin and saw that participants' symptoms of depression decreased significantly after two treatments. 
  • These patients had been suffering with depression for an average of eighteen years, and had tried other methods of treatment.
  • The study recruited 24 people with a documented history of depression. Most participants had persistent symptoms of depression for two years before the study began. The average age was 39, and 16 were female. 
  • Most participants were white, but one was African-American. The participants were tapered off of antidepressants prior to the study to ensure a safe and appropriate exposure to the experimental treatment.
  • Recent studies have shown that psilocybin is a potent antidepressant. Researchers found that psilocybin helped patients with major depressive disorder. In addition, the compound eased anxiety in people with cancer. 
  • They also found that psilocybin helped cancer patients cope with the stress of their treatments.
  • Despite the dangers of psychedelic mushrooms, they may be a powerful tool to treat depression. 

One of the most promising trials was conducted at Imperial College London and has already produced some promising results. 

The trial was successful enough to receive a breakthrough therapy designation by the US Food and Drug Administration.

Research on psilocybin has also shown that it reduces blood flow in the amygdala, a part of the brain involved in the depression process. 

Researchers also observed that psilocybin mushroom causes loosening of connections between brain networks, which is a sign of a brain "resetting." 

This phenomenon may cause patients to question entrenched beliefs and break compulsive thought patterns.

No comments

Powered by Blogger.